Announcement PDF ASX ANNOUNCEMENT 18 August 2023 Results of Extraordinary General Meeting Sydney, Australia – 18 August 2023 – Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, advises that all resolutions at the Extraordinary General Meeting held today were carried on a poll. In accordance with ASX Listing Rule 3.13.2 and Section 251AA of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached. Phillip Hains Company Secretary Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889 Disclosure of Proxy Votes Automic GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 Radiopharm Theranostics Limited Extraordinary General Meeting Friday, 18 August 2023 In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting. Poll Results (if applicable) Proxy Votes Resolution 1 Ratification of prior issue of Completion Shares under the Stock Purchase Agreement Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed FOR AGAINST 101,703,06 P 104,010,447 6 97.78% 101,990,39 2 Ratification of prior issue of Options to advisors P 104,361,942 5 97.73% 2,307,381 2.22% 2,371,547 2.27% PROXY'S DISCRETION ABSTAIN 0 121,820 0 0.00% 0 0.00% FOR AGAINST 101,703,06 6 97.78% 101,990,39 5 97.73% 2,307,381 2.22% 2,371,547 2.27% Results OUTCOME S250U APPLICABLE 0 Passed n/a 121,820 Passed n/a ABSTAIN